Janus Kinase 1/2 Inhibition With Baricitinib in the Treatment of Juvenile Dermatomyositis

Brain. 2019 Mar 1;142(3):e8. doi: 10.1093/brain/awz005.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Azetidines
  • Dermatomyositis*
  • Humans
  • Interferon Type I*
  • Janus Kinase 1
  • Janus Kinase Inhibitors*
  • Sulfonamides

Substances

  • Azetidines
  • Interferon Type I
  • Janus Kinase Inhibitors
  • Sulfonamides
  • Janus Kinase 1
  • baricitinib